http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102142327-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate | 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102142327-B1 |
| titleOfInvention | Nanovesicles derived from Acinetobacter bacteria and Use thereof |
| abstract | The present invention relates to bacterial-derived vesicles of the genus Acinetobacter and uses thereof, and the present inventors have cardiovascular diseases such as malignant diseases such as gastric cancer, colorectal cancer, breast cancer, ovarian cancer, bladder cancer, myocardial infarction, myocardial disease, and stroke compared to normal persons. , It was experimentally confirmed that the vesicles were significantly reduced in clinical samples derived from patients such as diabetes, dementia, and Parkinson's disease, and that the vesicles significantly inhibited the secretion of inflammatory mediators by pathogenic vesicles. As a result of confirming the anti-cancer effect, bacterial-derived vesicles of the genus Acinetobacter according to the present invention are malignant diseases such as gastric cancer, colon cancer, breast cancer, ovarian cancer, bladder cancer, cardiovascular disease such as myocardial infarction, cardiomyopathy, stroke, diabetes, dementia , And Parkinson's disease, and may be usefully used for the purpose of developing a composition for preventing or treating the disease or inflammatory disease. |
| priorityDate | 2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.